HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

People On The Move: Appointments At UPSA, Bionorica And MHRA

Executive Summary

The latest European consumer health people news: Sanofi Consumer Healthcare's Van Rycke named CEO of UPSA; Bionorica's global business head steps down; MHRA names its first chief safety officer.

You may also be interested in...



EU Business News: Nestlé Acquires PronoKal, Bionorica Names International Head, Venture Life Gets New Partner

Round-up of the latest European consumer health industry news: Nestle Health Science has expanded its offering with the acquisition of weight management solution PronoKal; Germany's Bionorica has hired a new international business head; and the UK's Venture Life has appointed a Chinese distributor to grow sales of two of its key brands.

People On The Move: Appointments At Medice, AESGP And Neuraxpharm

The latest European consumer health people news: Medice hires Uwe Baumann to lead its global OTC operation; AESGP re-elects its executive team; and Neuraxpharm appoints its first chief operating officer.

EU Business Round-Up: Bionorica's Sales Hit By COVID, Precision Takes Kwai To Austria, Alfasigma Hires Italy Chief

The latest European consumer health news: Germany's Bionorica posts double-digit sales decline due to COVID; Precision Healthcare takes Kwai to Austria; and Alfasigma hires Janssen exec to lead expanded Italy business.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS151307

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel